*Department of Cardiology;

†Hubei Key Laboratory of Biological Targeted Therapy; and

‡Hubei Provincial Engineering Research Center of Immunological Diagnosis and Therapy for Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Reprints: Xiang Cheng, MD, PhD, Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, China (e-mail: [email protected]).

This work was supported by grants from the National Key Research and Development Program (2021YFC2500500 and 2022YFC2503501), the Chinese Society of Cardiology Foundation (HFCSC2019B02), and Hubei Natural Science Foundation (2020CFA020) to Xiang Cheng.

The authors report no conflicts of interest.

Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Web site (www.jcvp.org).

The data underlying this article will be shared on reasonable request to the corresponding author.

Joint first authors: M. Yu, Z.-F. Zhu and F. Yang contributed equally to the study.